Tamoxifen is recommended as first line endocrine therapy for premenopausal women with estrogen receptor О± ER positive breast cancer 1 clomid online pharmacy Placebo control Incomplete outcome data attrition bias All outcomes Low risk No withdrawals or dropouts Selective reporting reporting bias High risk Data on miscarriage and side effects cannot be used in analysis, as these data were combined with the extra open label 3 month data